Anticancer fungal natural products: Mechanisms of action and biosynthesis.
Yuan S, Gopal JV, Ren S, Chen L, Liu L, Gao Z.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2020.112502 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för o-chloroacetylcarbamoylfumagillol. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
16 träffarAntiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba.
Monsen PJ, Luzzio FA.
J Nat Prod · journal article · DOI 10.1021/acs.jnatprod.8b00284Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.
Zhang F, Bhat S, Gabelli SB, Chen X, Miller MS, Nacev BA, Cheng YL, Meyers DJ, Tenney K, Shim JS, Crews P, Amzel LM, Ma D, Liu JO.
J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm400227zSynthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.
Sun J, Li MH, Qian SS, Guo FJ, Dang XF, Wang XM, Xue YR, Zhu HL.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2013.03.068Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.
Hou YP, Sun J, Pang ZH, Lv PC, Li DD, Yan L, Zhang HJ, Zheng EX, Zhao J, Zhu HL.
Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2011.08.063Identification, structural properties and chelating capacity of miltipolone as a broad-spectrum inhibitor to cancer cells.
Wang J, Chen S, Cheng H, Yang F, Wan J, Bo J, Liu Y, Yang J, Liu J, Zhou GC.
Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2011.01.026Synthesis and inhibitory evaluation of cyclohexen-2-yl- and cyclohexyl-substituted phenols and quinones to endothelial cell and cancer cells.
Liu X, Ou Y, Chen S, Lu X, Cheng H, Jia X, Wang D, Zhou GC.
Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2010.01.051Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.
Chem Res Toxicol · research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1021/tx900326kAntiparasitic activities of novel, orally available fumagillin analogs.
Arico-Muendel C, Centrella PA, Contonio BD, Morgan BA, O'Donovan G, Paradise CL, Skinner SR, Sluboski B, Svendsen JL, White KF, Debnath A, Gut J, Wilson N, McKerrow JH, DeRisi JL, Rosenthal PJ, Chiang PK.
Bioorg Med Chem Lett · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmcl.2009.07.029A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.
Sashidhara KV, White KN, Crews P.
J Nat Prod · research support, non-u.s. gov't; research-article; review; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1021/np800817ySynthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Galal AM, Gul W, Slade D, Ross SA, Feng S, Hollingshead MG, Alley MC, Kaur G, ElSohly MA.
Bioorg Med Chem · research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmc.2008.11.050TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
Nakayama S, Uto Y, Tanimoto K, Okuno Y, Sasaki Y, Nagasawa H, Nakata E, Arai K, Momose K, Fujita T, Hashimoto T, Okamoto Y, Asakawa Y, Goto S, Hori H.
Bioorg Med Chem · journal article · DOI 10.1016/j.bmc.2008.07.003Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP, Fisher PW, Hofmann GA, Kirkpatrick RB, Janson CA, Johnson RK, Ma C, Mattern M, Meek TD, Ryan MD, Schulz C, Smith WW, Tew DG, Tomazek TA, Veber DF, Xiong WC, Yamamoto Y, Yamashita K, Yang G, Thompson SK.
J Med Chem · journal article · DOI 10.1021/jm061182wFumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J, Chong CR, Hu X, Liu JO.
J Med Chem · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1021/jm060559vTotal synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
Jeong BS, Choi NS, Ahn SK, Bae H, Kim HS, Kim D.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2005.05.065Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2.
Han CK, Ahn SK, Choi NS, Hong RK, Moon SK, Chun HS, Lee SJ, Kim JW, Hong CI, Kim D, Yoon JH, No KT.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(99)00577-6